| Ytd | -29.65% | |
| 1y | -18.92% |
| Open | 7.05 | Prev Close | 7.05 | Low | 7.00 | High | 7.36 | Mkt Cap | 304.88M |
| Vol | 1.29M | Avg Vol | 1.14M | EPS | -1.14 | P/E | N/A | Forward P/E | -49.73 |
| Beta | 1.22 | Short Ratio | 4.55 | Inst. Own | 91.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 5.82 | 200-d Avg | 7.63 | 1yr Est | 41.90 |
RXST News
ALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced
Stifel analyst Tom Stephan maintains RxSight (NASDAQ:RXST) with a Hold and lowers the price targe
RxSight (NASDAQ: RXST - Get Free Report) and Futureworld (OTCMKTS:FWDG - Get Free Report) are both h
UBS analyst Patrick Wood maintains RxSight (NASDAQ:RXST) with a Neutral and raises the price targ
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
RxSight NASDAQ: RXST reported second-quarter revenue of $33.7 million, including $6.5 million recogn
RxSight (NASDAQ: RXST) reported second-quarter revenue of $33.7 million, including $6.5 million reco
RxSight, Inc. (RXST) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Es
ALISO VIEJO, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported f
RxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earning
ALISO VIEJO, Calif. , July 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced
RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The lat
RxSight, Inc. (NASDAQ:RXST) today announced a planned leadership transition effective July 20, 2026,
ALISO VIEJO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced
ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surger
RxSight NASDAQ: RXST reported preliminary second-quarter financial results and provided updates on i
RxSight, Inc. exhibits quantitative similarities to other small caps that I have rated here on Seeki
[url="]Glancy Prongay Wolke and Rotter LLP[/url], a leading national shareholder rights law firm, to
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder righ
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces it is investigating potenti
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz is investigating potential claims aga
B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and low
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
U.S. stock futures were mixed on Tuesday, as the Dow Jones index rose while the Nasdaq 100 and S&
US stock futures trade lower, investors focus on PENG, RXST, SAR earnings, RIVN's public offerin
Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m
RxSight (NASDAQ:RXST) raises FY2026 sales outlook from $120.000 million-$135.000 million to $140.000
RxSight, Inc. (NASDAQ:RXST) today announced select preliminary financial results for the second quar
Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxS
Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:RXST) with a Equal-Weight and lower
Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price targe
2026 Guidance: The company's 2026 financial guidance is as follows:Revenue of $120 to $135 milli
Stifel analyst Tom Stephan maintains RxSight (NASDAQ:RXST) with a Hold and lowers the price targe
UBS analyst Danielle Antalffy maintains RxSight (NASDAQ:RXST) with a Neutral and raises the price
Piper Sandler analyst Adam Maeder maintains RxSight (NASDAQ:RXST) with a Neutral and lowers the p
Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:RXST) with a Equal-Weight and lower
RxSight (NASDAQ:RXST) reported quarterly losses of $(0.03) per share which beat the analyst consensu
